Getting under the skin: The immunogenetics of psoriasis

被引:352
作者
Bowcock, AM [1 ]
Krueger, JG
机构
[1] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[2] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nri1689
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Psoriasis is a chronic inflammatory disorder of the skin that is mediated by T cells, dendritic cells and inflammatory cytokines. We now understand many of the cellular alterations that underlie this disease, and genomic approaches have recently been used to assess the alterations of gene expression in psoriatic skin lesions. Genetic susceptibility factors that contribute to predisposition to psoriasis are now also being identified. It is hoped that we will soon be able to correlate the cellular pathogenesis that occurs in psoriasis with these genetic factors. In this Review article, we describe what is known about genes that confer increased susceptibility to psoriasis, and we integrate this with what is known about the molecular and cellular mechanisms that occur in other inflammatory and autoimmune disorders.
引用
收藏
页码:699 / 711
页数:13
相关论文
共 133 条
  • [1] CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
    Abrams, JR
    Lebwohl, MG
    Guzzo, CA
    Jegasothy, BV
    Goldfarb, MT
    Goffe, BS
    Menter, A
    Lowe, NJ
    Krueger, G
    Brown, MJ
    Weiner, RS
    Birkhofer, MJ
    Warner, GL
    Berry, KK
    Linsley, PS
    Krueger, JG
    Ochs, HD
    Kelley, SL
    Kang, SW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) : 1243 - 1252
  • [2] Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells
    Abrams, JR
    Kelley, SL
    Hayes, E
    Kikuchi, T
    Brown, MJ
    Kang, SW
    Lebwohl, MG
    Guzzo, CA
    Jegasothy, BV
    Linsley, PS
    Krueger, JG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) : 681 - 693
  • [3] Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
    Aggarwal, S
    Ghilardi, N
    Xie, MH
    de Sauvage, FJ
    Gurney, AL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) : 1910 - 1914
  • [4] Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis
    Ahnini, RT
    Camp, NJ
    Cork, MJ
    Mee, JB
    Keohane, SG
    Duff, GW
    di Giovine, FS
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (06) : 1135 - 1140
  • [5] Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders
    Allen, M
    Ishida-Yamamoto, A
    McGrath, J
    Davison, S
    Iizuka, H
    Simon, M
    Guerrin, M
    Hayday, A
    Vaughan, R
    Serre, G
    Trembath, R
    Barker, J
    [J]. LABORATORY INVESTIGATION, 2001, 81 (07) : 969 - 976
  • [6] A non-HLA gene within the MHC in psoriasis
    Allen, MH
    Veal, C
    Faassen, A
    Powis, SH
    Vaughan, RW
    Trembath, RC
    Barker, JNWN
    [J]. LANCET, 1999, 353 (9164) : 1589 - 1590
  • [7] Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus
    Asumalahti, K
    Veal, C
    Laitinen, T
    Suomela, S
    Allen, M
    Elomaa, O
    Moser, M
    de Cid, R
    Ripatti, S
    Vorechovsky, I
    Marcusson, JA
    Nakagawa, H
    Lazaro, C
    Estivill, X
    Capon, F
    Novelli, G
    Saarialho-Kere, U
    Barker, J
    Trembath, R
    Kere, J
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (05) : 589 - 597
  • [8] A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele
    Asumalahti, K
    Laitinen, T
    Itkonen-Vatjus, R
    Lokki, ML
    Suomela, S
    Snellman, E
    Saarialho-Kere, U
    Kere, J
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (10) : 1533 - 1542
  • [9] Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+CD8+CD3+CTLs as determined by phenotypic analysis
    Austin, LM
    Coven, TR
    Bhardwaj, N
    Steinman, R
    Krueger, JG
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 1998, 25 (02) : 79 - 88
  • [10] The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients
    Austin, LM
    Ozawa, M
    Kikuchi, T
    Walters, IB
    Krueger, JG
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) : 752 - 759